| Literature DB >> 26058014 |
Yang Liu1,2, Attila Mándi3, Xiao-Ming Li4, Ling-Hong Meng5,6, Tibor Kurtán7, Bin-Gui Wang8.
Abstract
Peniciadametizine A (1); a newEntities:
Keywords: Penicillium adametzioides; antifungal activity; endophytic fungus; marine sponge; secondary metabolites
Mesh:
Substances:
Year: 2015 PMID: 26058014 PMCID: PMC4483649 DOI: 10.3390/md13063640
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of the isolated compounds 1–4 and reference compound pretrichodermamide A.
1H-, 13C-NMR and HMBC data of compounds 1 and 2.
| No. | 1 (Acquired in DMSO- | 2 (Acquired in Acetone- | ||||
|---|---|---|---|---|---|---|
| δC
| δH ( | HMBC | δC
| δH ( | HMBC | |
| 1 | 161.7, C | 164.9, C | ||||
| 2 | 100.8, C | 129.0, C | ||||
| 3 | 158.7, C | 160.9, C | ||||
| 4 | 70.4, C | 68.1, C | ||||
| 5 | 36.8, CH2 | 3.58, d (14.0) | 1, 4, 6, 7, 11 | 33.0, CH2 | 2.09, d (15.0) | 6, 7 |
| 2.98, d (14.0) | 2.54, d (15.0) | |||||
| 6 | 129.7, C | 74.0, C | ||||
| 7 | 122.2, CH | 5.82, d (2.5) | 6, 8 | 75.2, CH | 4.40, br s | 6, 8 |
| 8 | 122.4, CH | 5.76, dd (10.0, 2.5) | 6, 10 | 130.3, CH | 5.54, br d (10.4) | 6, 10 |
| 9 | 132.2, CH | 5.69, br d (10.0) | 7, 11 | 128.9, CH | 5.60, br d (10.4) | 7, 11 |
| 10 | 69.5, CH | 4.54, br dd (13.5, 4.5) | 65.9, CH | 4.65, br s | 9 | |
| 11 | 91.4, CH | 4.92, d (13.5) | 10 | 89.8, CH | 4.00, d (8.2) | 6, 10 |
| 12 | 53.5, CH | 4.95, br s | 2, 3, 13, 14, 23 | 118.1, CH | 7.25, s | 3, 14, 18 |
| 13 | 118.3, C | 115.6, C | ||||
| 14 | 149.7, C | 150.1, C | ||||
| 15 | 132.3, C | 137.1, C | ||||
| 16 | 153.1, C | 154.8, C | ||||
| 17 | 107.0, CH | 6.76, d (8.4) | 13, 15, 16 | 104.8, CH | 6.66, d (8.7) | 13, 15 |
| 18 | 119.2, CH | 6.94, d (8.4) | 12, 14, 16 | 126.0, CH | 6.90, d (8.7) | 14, 16 |
| 19 | 60.2, CH3 | 3.73, s | 15 | 61.0, CH3 | 3.79, s | 15 |
| 20 | 56.2, CH3 | 3.80, s | 16 | 56.4, CH3 | 3.89, s | 16 |
| 21 | 28.2, CH3 | 2.78, s | 1, 2 | 35.6, CH3 | 2.91, s | 1, 2 |
| 22 | 13.2, CH3 | 2.36, s | 4 | 13.9, CH3 | 2.26, s | 4 |
| 23 | 13.0, CH3 | 1.78, s | 12 | |||
| 10-OH | 5.29, d (4.5) | |||||
Measured at 125 MHz. Measured at 500 MHz. Multiplicities were determined by DEPT and HSQC experiments.
Figure 2Key 1H–1H COSY and HMBC correlations of compounds 1 and 2.
Figure 3Measured NOE correlations of 1 shown on the lowest-energy B97D/TZVP computed conformer of (2R,4R,10R,11R,12R)-1 and lowest-energy conformer of (2S,4R,10R,11R,12R)-1.
Figure 4Structures and Boltzmann populations of B97D/TZVP conformers Polarizable Continuum Model (PCM) solvent model for MeCN) of (2R,4R,10R,11R,12R)-1.
Figure 5Experimental ECD (black) spectrum of 1 compared with BH & HLYP/TZVP ECD spectra (blue) of (2R,4R,10R,11R,12R)-1 computed for the B97D/TZVP conformers (PCM/MeCN). Bars represent the computed rotational strengths of the lowest-energy conformer.
Figure 6Structure of the lowest-energy B97D/TZVP conformer (PCM solvent model for MeCN) of (4R,6S,7R,10R,11S)-2 with the measured NOE correlations.
Figure 7Structures and Boltzmann populations of B97D/TZVP conformers (PCM solvent model for MeCN) of (4R, 6S, 7R, 10R,11S)-2.
Figure 8Experimental ECD (black) spectrum of 2 compared with BH & HLYP/TZVP ECD spectra (blue) of (4R,6S,7R,10R,11S)-2 computed for the B97D/TZVP conformers (PCM/MeCN). Bars represent the computed rotational strengths of the lowest-energy conformer.
Scheme 1Proposed biosynthetic pathway for 1 and 2.